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Plasma-sprayed hydroxyapatite coatings were employed industrially for decades to improve osteointe-
gration of articular implants, but many studies have warned about the problems inherent to this pro-
cedure (mechanical properties, harmful phases). Consequently, a combination of hydroxyapatite with
TiO2 sprayed by high velocity oxy-fuel spray was considered in this study. As infection after joint
replacement surgery is one of the most critical concerns when considering implant performance, it is
necessary to study possible ways to reduce or eliminate it. Two coating treatments were chosen for this
study: addition of a percentage of ZnO and immersion in gentamicin for 24 h. Furthermore, three
bacteria were considered: Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. The
evolution of bacteria viability in solution was measured at 0, 2, and 4 h; and plate assays were performed
to study antibacterial effects by diffusion. The results show an important antibacterial effect of the
as-sprayed coating, attributed to the presence of -OH radicals on the surface. The presence of ZnO did
not have any additional influence on bacteria viability, but gentamicin-treated samples showed an
improvement in antibacterial behavior for Gram-negative bacteria in solution, as well as a bactericidal
effect in diffusion conditions.
Keywords antibacterial coatings, biomaterials, hydroxyapa-
tite, HP/HVOF, TiO2
1. Introduction
Infection in joint prostheses has been a major concern
for years as it is the main cause of implant failure after
short implantation times (Ref 1). Prosthesis implantation
requires exceptional asepsis because of the large exposi-
tion area and the influence of a massive implant that lead
to an important contamination risk (Ref 2). The patients
skin, airborne particles of the medical staff, or contami-
nated surgical material are the main sources of bacteria
found in infected prostheses after removal (Ref 2, 3),
which means that bacteria such as S. aureus, or different
kinds of Pseudomonas or Streptococcus are some of the
most common in these situations (Ref 3, 4).
As infection has devastating effects on the patient,
research into possible solutions to this problem is a
pressing field. In recent years, improvements in opera-
tional theater design and the use of systemic or local
antibiotics and other antibacterial compounds directly
present on the implant have decreased infection rates
(Ref 3).
Among the use of these antibacterial compounds, the
use of nanometric species is very well known and has
many advantages. A small particle size, high surface area,
and the capacity to produce oxygen species make nano-
metric species toxic, and this toxicity can be harnessed for
bactericide purposes (Ref 5). ZnO nanoparticles are
commonly used, due to the proven toxicity of the dis-
solved metallic ions, and the generation of oxyradical
species in solution (this oxidative stress weakens and kills
many kinds of bacteria). Furthermore, ZnO is itself an
essential micro-nutrient for eukaryote organisms, and a
‘‘safe’’ product widely used in personal care (Ref 6).
Another possibility considered to prevent infection
directly on the prosthesis is antibiotic loading. This
approach is very common for bone cements (Ref 7) or
biomimetic hydroxyapatite coatings (Ref 8), where it is
easy to incorporate the antibiotic into the production of
the cement or coating. Gentamicin sulfate, which belongs
to the aminoglycoside antibiotic family, is extremely effi-
cient against the majority of microorganisms responsible
for bone infection, even when the infection is deep. It is,
therefore, one of the most employed antibiotics, exten-
sively used with success in orthopedics, since 1970s, in
combination with bone cements (Ref 9).
Metallic materials have been employed for decades for
large-bone or load-bearing replacements due to their
mechanical properties (Ref 10). However, these materials
are bioinert, and a fibrous capsule is formed between the
implant and the surrounding bone that avoids the direct
bonding between them and leads to an early failure of the
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device (consequence of micro-motion and an inadequate
load distribution, corrosion problems, or the resultant
damage of the surrounding tissues) (Ref 11-14). As a
solution to this problem, the combination of the
mechanical properties of a metal and the biological
properties of a bioceramic coating was soon proposed
(Ref 15), to ensure the bonding implant tissue. Hydroxy-
apatite is industrially the most employed bioceramic for
this purpose, deposited by means of thermal spray tech-
nologies, specifically plasma-spraying (Ref 15).
Although in terms of effectiveness and productivity, the
thermal spray techniques are the best choice, many studies
widely showed the problems inherent to the plasma-
sprayed hydroxyapatite coatings (Ref 16). The physio-
logical behavior of the coated prosthesis is better than that
of the uncoated, but the high temperatures inherent to the
plasma process degrade the initial powders, leading to the
formation of unwanted phases such as calcium oxide
(harmful) or amorphous phases (easily dissolved)
(Ref 16).
An approach to solve these problems is the addition of
materials with better mechanical properties to the starting
powder (e.g., carbon nanotubes to improve toughness and
abrasion resistance (Ref 17, 18), silicium oxide to improve
adherence and corrosion resistance (Ref 19, 20), ceramic
interlayers (Ref 21), etc.). In this study, the addition of a
low amount (20wt.%) of TiO2 was considered, which
previously proved to increase the mechanical properties of
the coating without the loss of biological properties. The
other approach considered was the substitution of plasma
spraying by other thermal spray technique with lower
beam temperatures, specifically high velocity oxy-fuel
spray (HVOF). Previous studies showed the lower
degradation of the starting material using this technique
(Ref 22). Therefore, the starting material is a mixture of
80 wt.%HAp-20 wt.%TiO2 sprayed using HVOF onto a
substrate widely used in biomedical applications, TiAlV.
This work focuses then on a first comparison between
the two antibacterial approaches cited in the first para-
graphs applied to the starting material. The production
process of the treated coatings, their characterization, as
well as the bacterial tests performed with three bacteria
(Escherichia coli, Pseudomonas aeruginosa, and Staphy-
lococcus aureus) at different short times are reported in
this paper.
2. Experimental Method
The initial powder was a combination that previously
proved to have good biological and mechanical properties
(Ref 23). It was a mechanical mixture of a Sulzer-Metco
rutile powder (20 wt.%) and a hydroxyapatite powder
(80 wt.%; Plasma-Biotal Ltd.), and its characterization is
reported elsewhere (Ref 24). The substrate used was
Ti6Al4V (5 9 5 mm2 sheets), previously grit blasted in
order to reach a surface roughness that ensured the opti-
mum adhesion of the coating to the substrate. The thermal
spray equipment was a Sulzer-Metco DJH 2600 HVOF
system. The spraying conditions are listed in Table 1.
The ZnO was an American Elements agglomerated
nanopowder. Its granulometric distribution was analyzed
by laser light scattering (Beckman Coulter LS 13320),
dispersing the powder in water without ultrasound, and
the morphology was observed by scanning electron
microscopy (SEM), with Jeol JSM-5310 equipment. The
phases present were analyzed by x-ray diffraction. The
powder was incorporated into the previous mixture in
percentages of 2 and 5 wt.% (Ref 6, 25, 26), and the
resulting mixture was sprayed using the same conditions as
for the initial powder.
The sulfate gentamicin (Sigma Aldrich) treat-
ment, after initial tests, was chosen to be 24 h immer-
sion in Hanks solution with a concentration of 2 mg/mL,
at 37 C, followed by 60 min of drying at 55 C (Ref 9,
27, 28).




Compressed air (L/min) 264
Oxygen/propylene 3.96
Number of layers 5
Distance (mm) 200
Fig. 1 ZnO particles. Morphology by SEM












The surface and the cross-section of the coatings were
observed by SEM, in order to identify changes in the
microstructure. XRD analysis were done to the base
coating (non-treated HAp-TiO2 coating) to identify and
quantify the phases present. Additionally, energy-disper-
sive x-ray spectroscopy was used to analyze the three
surfaces and to identify element distribution, and infrared
spectroscopy was used to identify functional groups in the
as-sprayed samples.
The antibacterial activity of ZnO-treated and genta-
micin-treated samples was tested against the Gram-nega-
tive E. coli CECT405 and P. aeruginosa CECT116, and
the Gram-positive S. aureus CECT 239, obtained from the
Spanish Type Culture Collection. Overnight cultures of
bacteria on LB medium at 37 C with aeration were
diluted into a fresh medium, and incubated until the cul-
ture reached an optical density of 0.6 OD at 600 nm (mid
logarithmic phase of growth). The cells were harvested by
Fig. 2 Cross-section of the three samples
Fig. 3 Surfaces of the three samples: (a) as-sprayed, (b) with
ZnO (5%), (c) gentamicin-treated












centrifugation (5 min; 30009g), washed twice with Ringer
¼ solution, and adjusted to a final optical density of 0.6-0.7
(600 nm) with Ringer ¼ solution. All the samples were
poured into a vial with 1 mL of a 1:10 dilution of the
bacterial suspension in Ringer ¼ solution. The initial
bacteria concentration in the vial was approximately
5 9 107 CFU/mL. To ensure that any decrease in the
bacterial number was due to the exposure to different
samples, a control was included with bacterial cells at the
same initial concentration in Ringer ¼ solution without
any sample. The bacterial suspensions were incubated for
up to 4 h at 37 C and 200 rpm. Samples were taken at the
beginning (0 h) and after 2 and 4 h. After appropriate
dilutions, the samples were plated in LB agar and incu-
bated at 37 C. The viable bacteria were monitored by
counting the number of colony-forming units from the
appropriate dilution. To assay the antibacterial effect by
diffusion in plates, suspensions of the bacteria to be
assayed were prepared and dispersed in solid medium (LB
agar plates), and the different samples were dropped in
different zones on the agar plate. After overnight incu-
bation at 37 C, the presence of inhibition growth zones
was determined.
3. Results and Discussion
ZnO XRD characterization revealed that the powder
was in a crystalline wurtzite phase. Its granulometric dis-
tribution, a Gaussian bell curve between 10 and 50
microns, was very similar to those of the other two pow-
ders. The morphology of the particles can be observed in
Fig. 1. They had a spherical shape and porous structure
resulting from the agglomeration of the nanopowder.
The analysis of the cross-sections of the coatings
(Fig. 2) by SEM reveals compact microstructures, without
imperfections (pores or cracks), either for non-treated or
treated coatings, and the interface remains continuous.
Mechanical analysis would be adequate to corroborate
that the employed treatment do not affect the mechanical
performance of the coatings.
The observation of the coating surfaces (Fig. 3a-c)
showed that the surface of the as-sprayed sample is typical
in this kind of spray process (Ref 29-31). Splats, unmelted
particles, and splashes of the melted particles can be
Fig. 4 IR spectra of the as-sprayed sample, -OH zone
Fig. 5 EDX mapping of the cross-section of the gentamicin-
treated sample












identified in the micrographs. EDX analysis indicated, as
expected, the elements present in the initial powder and
the derived phases (tricalcium phosphates and anatase),
Ca, P, Ti, O, and C. Infrared spectroscopy of these sam-
ples (Fig. 4) allowed the identification of a peak indicating
the strong presence of -OH radicals on the surface.
The surface of the sample with ZnO (Fig. 3b) was very
similar to that of the as-sprayed one. The presence of
small amounts of ZnO did not influence the surface
microstructure. EDX analysis showed the presence of the
expected elements (the same than for the HAp-TiO2
samples) and also a peak corresponding to zinc. Quanti-
fication indicated that the amount of zinc by weight was
very close to the amount in the initial powder: 1.7 wt.%
for the sample with 2 wt.% ZnO into the powder mixture
and 4.4 wt.% for the sample with 5 wt.% ZnO into the
powder mixture. The ZnO was, therefore, considered to
be incorporated into the coating.
The surface of the gentamicin-treated sample (Fig. 3c)
showed the typical microstructure of a bioceramic coating
after a 24 h of immersion under physiological conditions.
An apatite layer on the surface had started nucleation in
different zones, in the form of globules. EDX analysis
identified nitrogen (present in the gentamicin) on the
Fig. 6 Effect of the ZnO treatment on the evolution of bacteria
survival in solution at 0, 2, and 4 h: (a) E. coli, (b) P. aeruginosa,
(c) S. aureus
Fig. 7 Effect of gentamicin on the evolution of bacteria survival
in solution at 0, 2, and 4 h: (a) E. coli, (b) P. aeruginosa, (c) S.
aureus












surface, but the limitations of the equipment made it
extremely difficult to detect this element. Only the
expected elements (present in the initial powder mixture),
plus peaks corresponding to sodium and chlorine (present
in Hanks solution) appeared. An EDX mapping of the
cross-section (Fig. 5) revealed that sodium chloride pen-
etrated to the layers near the substrate, by interconnected
porosity derived from the partial dissolution of the coating
after 24 h of immersion. The presence of a sodium chlo-
ride precipitation deep in the coating could be interpreted
as an indicator of the presence of the gentamicin at the
same levels. One consequence that could be expected is a
slow liberation of the gentamicin over time, as this gen-
tamicin must be released from such a deep level. The
progressive coverage of the surface by an apatite layer is
also expected to act as a stopper and helps the prevention
of the complete liberation of the antibiotic in the initial
stage of implantation.
XRD results showed that hydroxyapatite and rutile
were the main phases (the same than in the starting
powder), with small amounts of anatase and a-TCP. Broad
bands due to the presence of amorphous phases derived
from the thermal degradation of the initial powder were
also detected. Rietveld calculations quantified an amor-
phous phase amount of 14%, in front of 18% obtained
with HVOF-sprayed HAp, and 38% obtained with plas-
ma-sprayed hydroxyapatite. These results are a witness of
the good performance of these HAp-TiO2 coatings.
The bacterial test results are shown in Fig. 6 and 7. The
results with the samples with ZnO (Fig. 6) indicate that
the addition of this compound did not have a significant
effect on the behavior of any of the three bacteria. The
non-treated sample showed an equivalent antibacterial
effect as the samples with zinc oxide; or even higher. The
infrared spectra of the non-treated sample showed an
important peak attributed to the presence of -OH radicals.
According to the literature (Ref 32, 33), these radicals are
an important factor in the bactericide compounds, and
cause an oxidative stress that has a strong effect on some
kinds of bacteria. This could explain the antibacterial
effect of the as-sprayed samples. The bactericidal effect
was similar for the three bacteria, which could be an
indicator of the effect of oxidative stress on Gram-positive
and Gram-negative bacteria. The mere presence of the
coatings reduces by approximately 4-5 orders of magni-
tude the presence of bacteria in the solution with regard to
the controls, and consequently the presence of bacteria is
reduced 100%. An interpretation of the slightly lower
bactericide effect of the ZnO samples could be the lower
presence of -OH radicals on the surface due to the partial
coverage of the surface with ZnO. The fact that a well-
known bactericide compound such as ZnO showed no
effect in this case could be attributed to the bactericidal
effect of zinc only for Zn2+ concentrations above 4-8 mM
(the minimum inhibitory concentration) (Ref 6), and it is
possible that this concentration was not reached in these
cases. Further research is required to clarify the evolution
of the concentration of zinc ions in solution at different
culture times.
Concerning the tests with gentamicin, the results in
Fig. 7 show that the blank coating (without gentamicin)
also induced a reduction of bacteria viability, again a sign
of the important antibacterial effect of the non-treated
samples (the reduction of the viability was nearly 100%).
Nevertheless, an improvement was detected for the trea-
ted samples. The addition of gentamicin clearly allowed an
extra antibacterial effect against Gram-negative bacteria
(which is especially important for resistant microorgan-
isms such as P. aeruginosa), whereas for S. aureus there
was no marked difference with and without gentamicin.
Antibactericidal tests under diffusion conditions allowed
the identification of differences between the samples. As an
example, the E. coli assay can be observed in Fig. 8.
Whereas for the ZnO and the non-treated samples, the
antibactericidal effect by diffusion was not detectable; the
gentamicin-treated samples clearly showed a growth inhi-
bition zone around them. This capacity against bacteria by
diffusion mechanisms makes the treatment with gentamicin
Fig. 8 Antibacterial test against E. coli of: (a) samples treated with ZnO and (b) samples treated with gentamicin












a good alternative, since it combines excellent antibacterial
behavior in solution with an antibacterial effect by contact
and diffusion, which makes it more appropriate for physi-
ological conditions (both solution and diffusion conditions
are important in such a situation).
4. Conclusion
Plasma-sprayed hydroxyapatite coatings, usually
employed to improve tissue-implant bonding, show limited
functionality. A combination HAp-TiO2 sprayed by HVOF
was chosen instead, to improve this functionality. Infection is
also a major concern to these coatings, that is why research
about antibacterial compounds is important. In this study,
two antibacterial treatments were compared over short times
in order to establish which one was the most appropriate for
biomedical applications. The previous study of the coatings
showed that the microstructure was maintained after the
treatments, which validates their employment. Non-treated
samples showed an important bactericidal effect in solution
with the three bacteria analyzed, provided by the presence of
-OH radicals. ZnO was found not to add any extra antibac-
terial activity to the samples, and the treated coatings showed
comparable bactericide effects to the non-treated ones.
Nevertheless, it was the gentamicin treatment that showed
best behavior in solution as well as an important antibacterial
effect by diffusion. Further research should be performed in
order to study the antibacterial behavior over longer times,
and the release kinetics of gentamicin and zinc ions. Possible
alternatives include a two-stage spraying, before and after
the gentamicin treatment, in order to block the immediate
release with the superior layers; or search for a way to
incorporate gentamicin in the initial mixture to avoid its
degradation during the spray (inside non-conductor parti-
cles, for instance) and have more control over the release
kinetics.
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